What would be the outcome if the American Diabetes Association recommendations of 2010 had been followed in our pratice in 1998–2006?
- 12 April 2011
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 28 (5) , 567-574
Abstract
Diabet. Med. 28, 567–574 (2011) Aims In 2010, the American Diabetes Association has published recommendations on the population to be screened for dysglycaemia; the diagnostic criteria for intermediate hyperglycaemia and diabetes using oral glucose tolerance testing and HbA1c; and the patients eligible for treatment with metformin. We aimed to evaluate the consequences of screening with oral glucose tolerance test or HbA1c in an at‐risk population.Methods Among 1177 overweight or obese consecutive adults without known diabetes who were referred to our department for weight management, we selected 1157 individuals (83% female; 80% European) fulfilling the American Diabetes Association 2010 criteria for dysglycaemia screening.Results Mean age was 41.2 ± 13 years, BMI 37.0 ± 7.2 kg/m2, fasting plasma glucose 4.9 ± 0.8 mmol/l and HbA1c (turbidimetric immunoassay) 5.7 ± 0.7% (39 mmol/mol). Based on oral glucose tolerance test and HbA1c, respectively, 76 (6.6%) and 113 (9.8%) patients had diabetes, including 34 sharing both criteria; 307 (26.5%) and 478 (41.3%) had intermediate hyperglycaemia; and 130 (11.2%) and 255 (22.0%) would be treated with metformin. The sensitivity/specificity of HbA1c ≥ 6.5% (48 mmol/mol) for the diagnosis of diabetes according to the oral glucose tolerance test were 44.7/92.7%. Diabetes risk scores and UK Prospective Diabetes Study cardiovascular risk score were the highest in the 130 patients having both an abnormal oral glucose tolerance test and HbA1c ≥ 5.7%.Conclusions In a population at risk for diabetes, the HbA1c strategy could lead to diagnosing more cases of dysglycaemia and to treating more patients with metformin than the oral glucose tolerance test strategy. The consistency of either diagnostic criteria was low. The patients with the highest a priori risk of diabetes and cardiovascular disease were those fulfilling both oral glucose tolerance test and HbA1c criteria.Keywords
This publication has 28 references indexed in Scilit:
- Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic AdultsNew England Journal of Medicine, 2010
- Standards of Medical Care in Diabetes—2010Diabetes Care, 2010
- International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of DiabetesDiabetes Care, 2009
- Relationship between glycated haemoglobin and microvascular complications: Is there a natural cut-off point for the diagnosis of diabetes?Diabetologia, 2009
- Predicting Diabetes: Clinical, Biological, and Genetic ApproachesDiabetes Care, 2008
- Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C MeasurementDiabetes Care, 2007
- Use of HbA1c in Predicting Progression to Diabetes in French Men and WomenDiabetes Care, 2006
- Utility of hemoglobin A1c in predicting diabetes riskJournal of General Internal Medicine, 2004
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 1997
- Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose IntoleranceDiabetes, 1979